SIH refers to elevated blood glucose levels during GCs therapy and includes both patients without and with pre-existing type 2 diabetes mellitus (T2DM)
In a clinical trial including 2,605 people with heart failure but no prior history of diabetes, dapagliflozin (10 mg daily) led to a 32% reduction in new diabetes incidence over a median follow-up of 18 months (Barbarawi 2021
Efficacy of black cohosh ( Cimicifuga racemosa L.) in treating early symptoms of menopause: A randomized clinical trial
There is no TGA-registered BPC-157 product for therapeutic use in Australia, and as of June 2024 BPC-157 is a Schedule 4 (prescription-only) substance, meaning any legal supply must come through a doctors prescription via a compounding pharmacy
The measurement of brachial flow-mediated dilation (FMD) is often used as a surrogate marker of endothelial function
Our Metabolism Boost IV is specifically designed to rev up your bodys metabolic rate, promote fat burning, and support overall metabolic health
